These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3274567)

  • 1. The importance of HLA-DR matching in corneal transplant recipients treated with cyclosporine A.
    von Keyserlingk H; Offermann G; Wiederholt M; Hoffmann F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2576-8. PubMed ID: 3274567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rejection following corneal transplantation. Effect of HLA compatibility of the grafts].
    Boisjoly HM; Dubé I; Laughrea PA; Roy R; Bernard PM
    Clin Invest Med; 1989 Aug; 12(4):221-3. PubMed ID: 2535434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposing factors in corneal graft rejection.
    Hoffmann F; Pahlitzsch T
    Cornea; 1989 Sep; 8(3):215-9. PubMed ID: 2663348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of HLA-DR/RFLP matching in complicated corneal transplantations.
    Baggesen K; Lamm LU; Ehlers N
    Clin Transpl; 1990; ():197-201. PubMed ID: 1983294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of HLA DR matching for corneal transplantation in high-risk cases.
    Hoffmann F; von Keyserlingk HJ; Wiederholt M
    Cornea; 1986; 5(3):139-43. PubMed ID: 2980829
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
    Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
    [No Abstract]   [Full Text] [Related]  

  • 9. Histocompatibility antigens.
    Taylor CJ; Dyer PA
    Eye (Lond); 1995; 9 ( Pt 2)():173-9. PubMed ID: 7556713
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of HLA matching in cardiac allograft recipients in a single center.
    Raffoux C; Mayor V; Cabrol C; Busson M; Hors J; Colombani J
    Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858
    [No Abstract]   [Full Text] [Related]  

  • 13. Negative effect of HLA-DR matching on corneal transplant rejection.
    Bradley BA; Vail A; Gore SM; Rogers CA; Armitage WJ; Nicholls S; Easty DL
    Transplant Proc; 1995 Feb; 27(1):1392-4. PubMed ID: 7878924
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [At-risk keratoplasty, HLA antigens and cyclosporin A].
    Martin XD; Ganzfried R
    Klin Monbl Augenheilkd; 1990 May; 196(5):301-3. PubMed ID: 2366459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective HLA-DR matching in penetrating keratoplasty.
    Van Der Hauwaert N; Mangelschots E; Foets B; Emonds MP; Spaepen M; Missotten L
    Bull Soc Belge Ophtalmol; 1995; 257():27-30. PubMed ID: 8696521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA matching and corneal transplantation.
    Armitage WJ
    Eye (Lond); 2004 Mar; 18(3):231-2. PubMed ID: 15004569
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DR1 recipients have the highest kidney transplant survival.
    Cook DJ; Cecka JM; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.